Applied Cells Announces Evaluation of Its New MARS Platform at The University of Pennsylvania

Under an instrument evaluation agreement, researchers at the University of Pennsylvania will explore utilization of “MARS” platform of Applied Cells to assist in protocol development for areas of advanced cancer diagnosis and cancer treatment. Santa Clara, California - University of Pennsylvania (Penn) and Applied Cells, Inc., a Santa Clara, California based biotechnology company, announced today [...]

Genomic Vision Technology to Be Tested by NIST (US Gaithersburg) for Establishing Standards Methods for Genome Editing Based Product Registration by FDA

Genomic Vision (Paris:GV) (FR0011799907 – GV), a biotechnology company developing molecular assays and Artificial Intelligence tools to control quality and safety of genetically modified genomes, today announced that its Molecular Combing technology will be used by the US National Institute of Standards and Technology (NIST) to characterize and quantify intended and unintended genome editing events in [...]

Biosero Releases New Green Button Go™ Software that Increases Traceability, Visibility and Compliance in the Lab

SAN DIEGO – SLAS 2020 – Biosero, Inc. will release new Green Button GoTM software products and features, as well as a version that is certified 21 CFR Part 11 compliant, at the 2020 Society for Laboratory Automation and Screening Conference (SLAS 2020) in San Diego, California. “You can have all the data in the world, but if you can’t visualize [...]

DIVESTMENT OF EMS BRÜEL & KJÆR

Spectris plc ('Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that, together with Macquarie Corporate Holdings Pty Limited (‘Macquarie’), it has agreed to divest the EMS Brüel & Kjær joint venture ('EMS B&K') to Envirosuite Limited (‘Envirosuite’). Envirosuite is an environmental management technology company and is listed on the Australian Securities Exchange. [...]

CellFE Raises $3.6M in Seed Round Co-led by Cota Capital and Dynamk Capital

SAN CARLOS, Calif., Jan. 16, 2020 -- CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has raised $3.6 million in an initial Series Seed. The oversubscribed round is co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures. The round is expected to close with additional investors [...]

LUM trains the worldwide sales experts on the new particle measurement devices and looks optimistically into the future

( Berlin,16/1/20)  From January 27th to 29th the International Sales Meeting will take place at the headquarters of LUM GmbH in Berlin-Adlershof for the 21st time in a row. The sales experts of the LUM companies from Asia, Europe and North America exchange technical information with external sales partners from all over the world. This is where [...]

Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema

SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children and one in 12 adults. The aim of the collaboration is to help the medical [...]

Discover 18 Wells for Cost-Effective Cell Culture and High-Resolution Microscopy

Munich, Germany – Perform high-resolution, cost-effective cell culture experiments with ibidi’s latest innovative labware technology, the µ-Slide 18 Well family. With its thin ibidi Polymer Coverslip Bottom, the µ-Slide 18 Well allows for excellent cell adhesion onto the tissue culture-treated surface. In addition, it has the highest optical quality and is ideally suited for a variety of [...]

Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages

The partnership aligns with Civica’s strategy to make quality medications available and affordable   SALT LAKE CITY, UT, January 16, 2020 – Civica Rx (Civica, Inc.) today announced it has signed a longterm agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with [...]

Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program

-- Contract Focused on Making DNA Data Storage Commercially Accessible -- SAN FRANCISCO-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has been selected as a subcontractor to Georgia Tech Research Institute (GTRI) to undertake the DNA [...]

Access IBO on Knowledge Center